Risk Factors of Hyperammonemia in Patients with Epilepsy Under Valproic Acid Therapy
Medicine 93:e66, Tseng, Y.L.,et al, 2014
Acute Hepatic Failure Associated with the Use of Sodium Valproate
NEJM 300:962-966, Suchy,F.J.,et al, 1979
Valproic Acid, Review of a New Antiepileptic Drug
Arch Neurol 36:393-398, Bruni,J.,et al, 1979
Effect of Valproic Acid on Hepatic Function
Neurol 28:961-964, Willmore,L.J.,et al, 1978
Valproate Therapy and Nonalcoholic Fatty Liver Disease
Ann Neurol 55:729-732, Luef,G.J.,et al, 2004
Clumsiness, Confusion, Coma, and Valproate
Lancet 353:1408, Ellaway,C.J.,et al, 1999
Valproic Acid Hepatic Fatalities. III. U. S. Experience Since 1986
Neurol 46:465-469, Bryant,A.E.&Dreifuss,F., 1996
Early Childhood Hepatocerebral Degeneration Misdiagnosed as Valproate Hepatotoxicity
Ann Neurol 32:767-775, Bicknese,A.R.,et al, 1992
Valproic Acid Hepatic Fatalities, II. US Experience Since 1984
Neurol 39:201-207, Dreifuss,F.E.,et al, 1989
Sodium Valproate
Editorial, Lancet 2:1229-12311988., , 1988
Valproic Acid Hepatic Fatalities:A Retrospective Review
Neurol 37:379-385, Dreifuss,F.E.,et al, 1987
Safe Readministration of Valproate after an Episode of Hepatotoxicity
Ann Neurol 13:688, Ramsay,R.E., 1983
Valproic Acid
NEJM 302:661-666, Brown,T.R., 1980